IRD vs T · rev $11.0M vs P/E 7.4, rev $125.65B
Opus Genetics, Inc. (IRD) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
IRD currently screens at market cap $35.7M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the IRD and T stock pages for the full models.
Not investment advice.